Biotech

The Festival of Genomics & Biodata 2027

he Festival of Genomics & Biodata is the UK's largest life sciences event, bringing together scientists, clinicians, business leaders, tech companies, investors, patient organisations, and policymakers. The event covers AI, biodata, cancer diagnostics, drug discovery, genomic medicine, and more. It offers inspiring talks, hands-on exhibits, networking oppor…

Visit the official site

41Voices

16Underwriters

10Exhibitors

13On the bill · sessions

61Companies · in total

§I

The Voices

Programmed at The, in alphabetical order.

Adam Ameur

Associate Professor of Genomics and Bioinformatics · Uppsala University

Andrew Beggs

Professor of Cancer Genetics & Surgery · University of Birmingham

Andrew Parrish

Rare and Inherited Disease NHS Genomic Network of Excellence · Exeter Genomics Laboratory (South West GLH), Royal Devon University Healthcare NHS Foundation Trust

Anna Lindstrand

Director of the Clinical Genetics Diagnostic Laboratory · Karolinska University Hospital

Ben Goldacre

Director of Bennett Institute for Applied Data Science · University of Oxford

Bjarni V. Halldórsson

Principal Investigator · deCODE

Cathie Sudlow

Director of the Usher Institute · University of Edinburgh

Christopher Watson

Associate Professor of Molecular Diagnostics · University of Leeds

Clare Turnbull

Professor of Cancer Genetics · Institute of Cancer Research London

Dame Anna Dominiczak

Chief Scientific Adviser (Health) · Scottish Government

Dame Lyn Chitty

Chair of Genetics and Fetal Medicine · University College London

Dame Sue Hill

Chief Scientific Officer · NHS England

David Aanensen

Director, Centre for Genomic Pathogen Surveillance · Pandemic Sciences Institute

Edwin Cuppen

Scientific director · Hartwig Medical foundation

Elif Ozkirimli

Head of Computational Science Products · Roche

Emma Baple

Professor of Genomic Medicine · University of Exeter

Funmi Vanessa Ullam

Parent of a Child with a Chronic Condition

Isabel Oliver

Chief Medical Officer · Welsh Government

Jasmine Plummer

Director, Center for Spatial OMICs · St Jude Children's Research Hospital

Joanna Howson

Scientific Vice President · Novo Nordisk

Julio Saez-Rodriguez

Head of Research · EMBL-EBI

Lord Patrick Vallance

Minister of State · Science, Research and Innovation

— and 19 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.

ABPI

Advanced Therapies Wales

AGNC

Brandson

Genomics Partnership Wales

§III

The Programme

Selected from 13 sessions on the bill.

09:00 09:30
The Future for Genomics and the NHS Shaped by New Government Strategies
Main Stage
09:30 10:00
Evaluating Constellation: Insights into NHS Paediatric Acute Care Pathways
Main Stage
10:00 10:45
Panel Discussion: Practical Strategies to Deliver the Next Decade of UK Health and Care – What’s Next for Our NHS?
Main Stage
10:45 11:00
Hope, Perseverance, and the Promise of Advanced Therapies
Main Stage
11:30 12:00
Nanopore Sequencing to Understand and Diagnose Brain Tumours
Main Stage
12:00 12:30
Sequencing of the UK biobank using Oxford Nanopore
Main Stage
12:30 13:00
Panel Discussion: From Precision Medicine to Precision Analysis: Integrating Long-Reads as a Frontline Diagnostic
Main Stage
14:10 14:40
Long-read Sequencing for the Diagnosis of Primary Mitochondrial DNA Disorders
Main Stage
14:40 15:10
New Frontiers – HiFi Sequencing Technology Updates
Main Stage

Intermission

Part the Second · For the Buyer

What does it mean when 61 companies show up — and 3 bet on three roles at once?

“61 companies. three are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House

3All threespeak · spons · exh

13Sponsoringsponsor only

10Exhibitingexhibitor only

35Companies Speakingspeaker only

The Triple-Threat

UK Biobank·NHS England·Our Future Health

№ 02Fig. 02 — The Voices, by Seniority

54% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

C-suite820%
VP-level25%
Director / Head of1229%
Manager / Lead12%
Research / Science25%
Other roles1639%

Of 41 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room

№ 04Fig. 04 — By Tier

unspecified16

100% of 16

The Festival of Genomics & Biodata 2027

The Future for Genomics and the NHS Shaped by New Government Strategies

Evaluating Constellation: Insights into NHS Paediatric Acute Care Pathways

Panel Discussion: Practical Strategies to Deliver the Next Decade of UK Health and Care – What’s Next for Our NHS?

Hope, Perseverance, and the Promise of Advanced Therapies

Nanopore Sequencing to Understand and Diagnose Brain Tumours

Sequencing of the UK biobank using Oxford Nanopore

Panel Discussion: From Precision Medicine to Precision Analysis: Integrating Long-Reads as a Frontline Diagnostic

Long-read Sequencing for the Diagnosis of Primary Mitochondrial DNA Disorders

New Frontiers – HiFi Sequencing Technology Updates

“61 companies. three are betting more than once.”